Robert E. Grant

Robert E. Grant, CEO & President, Bausch + Lomb Surgical

ROBERT E. GRANT is chief executive officer and president, Surgical Products, for Bausch + Lomb. He was named to this post beginning August 2010.

In 2006, Mr. Grant began his tenure as Allergan’s corporate vice president and president, Allergan Medical, where he led the $3.4 billion Allergan-Inamed post-acquisition integration. His leadership at Allergan Medical was instrumental in creating the multi-billion dollar medical rejuvenation industry through a portfolio of products such as BOTOX® Cosmetic, JUVEDERM® injectable gel, NATRELLE® breast implants and the LAP-BAND® Adjustable Gastric Banding System.

Prior, Mr. Grant served as acting chairman, president and CEO of BIOLASE Technology, Inc., the global cosmetic dentistry company, where he led a highly successful turnaround, returning the company to profitability and revenue growth. He joined BIOLASE in 2003 as chief operating officer, and also served the organization as chief financial officer.
From 1997 to 2003, Mr. Grant held management positions with Lumenis, Inc., (formerly Coherent Medical Group), including executive vice president of its Ophthalmic Business Unit, executive vice president of its Surgical Business Unit, vice president of business development and managing director of European Operations. He has also held expatriate management positions with Sulzer Medica AG and Telectronics Pty Ltd. Mr. Grant has lived and worked in nine countries and is fluent in English, Japanese, French, Korean and German.

Mr. Grant earned his M.B.A. from the Thunderbird School of Global Management, and has a bachelor’s degree from Brigham Young University. He will be based in Aliso Viejo, Calif.